These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37124500)

  • 1. Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma
    Donovan J; Deng Z; Bian F; Shukla S; Gomez-Arroyo J; Shi D; Kalinichenko VV; Kalin TV
    Front Oncol; 2023; 13():1163510. PubMed ID: 37124500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma
    Donovan J; Deng Z; Bian F; Shukla S; Gomez-Arroyo J; Shi D; Kalinichenko VV; Kalin TV
    Front Oncol; 2023; 13():1112859. PubMed ID: 36816948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.
    Zhang X; Wang J; Wang Y; Liu G; Li H; Yu J; Wu R; Liang J; Yu R; Liu X
    Front Oncol; 2022; 12():911817. PubMed ID: 35530328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132.
    Cheng Y; Yuan X; Tian Q; Huang X; Chen Y; Pu Y; Long H; Xu M; Ji Y; Xie J; Tan Y; Zhao X; Song H
    Front Oncol; 2023; 13():1334938. PubMed ID: 38173839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
    Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.
    Yang W; Zou J; Li Y; Liu R; Yan Z; Chen S; Zhao X; Guo W; Huang M; Li W; Zhu X; Chen Z
    Front Oncol; 2022; 12():903586. PubMed ID: 35646700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
    Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
    J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
    Houghton PJ; Cheshire PJ; Hallman JC; Bissery MC; Mathieu-Boué A; Houghton JA
    Cancer Res; 1993 Jun; 53(12):2823-9. PubMed ID: 8504425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: A Novel Role of Connexin 40-Formed Channels in the Enhanced Efficacy of Photodynamic Therapy.
    Wu DP; Bai LR; Lv YF; Zhou Y; Ding CH; Yang SM; Zhang F; Wang YY; Huang JL; Yin XX
    Front Oncol; 2022; 12():853278. PubMed ID: 35280752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma.
    Xie S; Wang M; Zeng C; Ou Y; Zhao L; Wang D; Chen L; Kong F; Yi D
    Front Oncol; 2023; 13():1338060. PubMed ID: 38162493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines.
    Yuan B; Xu K; Shimada R; Li J; Hayashi H; Okazaki M; Takagi N
    Front Oncol; 2021; 11():778834. PubMed ID: 34692557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells.
    Chen X; Zhang Q; Dang X; Song T; Wang Y; Yu Z; Zhang S; Fan J; Cong F; Zhang W; Duan N
    J Cancer; 2021; 12(2):482-497. PubMed ID: 33391445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.
    Thompson J; George EO; Poquette CA; Cheshire PJ; Richmond LB; de Graaf SS; Ma M; Stewart CF; Houghton PJ
    Clin Cancer Res; 1999 Nov; 5(11):3617-31. PubMed ID: 10589779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.
    Shi J; Zhang Y; Wang J; Li J; Li Z
    Front Oncol; 2020; 10():583499. PubMed ID: 33330061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer.
    Zhou Y; Zhang Q; Wang M; Huang C; Yao X
    Front Oncol; 2022; 12():916983. PubMed ID: 35837110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
    J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Photodynamic therapy for malignant brain tumors in children and young adolescents.
    Chiba K; Aihara Y; Oda Y; Fukui A; Tsuzuki S; Saito T; Nitta M; Muragaki Y; Kawamata T
    Front Oncol; 2023; 13():1158407. PubMed ID: 37182164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study.
    Isowa M; Hamaguchi R; Narui R; Morikawa H; Wada H
    Front Oncol; 2023; 13():1291026. PubMed ID: 37799473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.
    Kurmasheva RT; Bandyopadhyay A; Favours E; Del Pozo V; Ghilu S; Phelps DA; Erickson SW; Peer CJ; Figg WD; Smith MA; Houghton PJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27820. PubMed ID: 31099166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.